Owens & Minor, Inc. (OMI) Expected to Post Quarterly Sales of $2.54 Billion
Analysts expect Owens & Minor, Inc. (NYSE:OMI) to post sales of $2.54 billion for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Owens & Minor’s earnings, with the highest sales estimate coming in at $2.59 billion and the lowest estimate coming in at $2.49 billion. Owens & Minor posted sales of $2.33 billion during the same quarter last year, which suggests a positive year over year growth rate of 9%. The company is expected to announce its next earnings results on Wednesday, November 7th.
On average, analysts expect that Owens & Minor will report full-year sales of $9.98 billion for the current year, with estimates ranging from $9.90 billion to $10.10 billion. For the next fiscal year, analysts expect that the firm will post sales of $10.31 billion per share, with estimates ranging from $10.18 billion to $10.58 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that follow Owens & Minor.
Owens & Minor (NYSE:OMI) last posted its earnings results on Tuesday, August 7th. The company reported $0.32 EPS for the quarter, missing the Zacks’ consensus estimate of $0.46 by ($0.14). The firm had revenue of $2.46 billion for the quarter, compared to analysts’ expectations of $2.45 billion. Owens & Minor had a negative net margin of 1.47% and a positive return on equity of 9.47%.
Shares of NYSE OMI traded down $1.70 during midday trading on Tuesday, reaching $16.31. The company had a trading volume of 126,362 shares, compared to its average volume of 735,389. The stock has a market cap of $1.13 billion, a P/E ratio of 10.54, a P/E/G ratio of 1.68 and a beta of 1.03. Owens & Minor has a 1 year low of $14.07 and a 1 year high of $29.85. The company has a current ratio of 1.77, a quick ratio of 0.91 and a debt-to-equity ratio of 2.08.
The business also recently declared a quarterly dividend, which will be paid on Monday, October 1st. Shareholders of record on Monday, September 17th will be issued a $0.26 dividend. The ex-dividend date is Friday, September 14th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 6.38%. Owens & Minor’s dividend payout ratio is currently 64.60%.
In related news, SVP Charles C. Colpo sold 11,000 shares of the firm’s stock in a transaction on Monday, August 27th. The shares were sold at an average price of $16.87, for a total transaction of $185,570.00. Following the completion of the transaction, the senior vice president now owns 20,944 shares of the company’s stock, valued at $353,325.28. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Geoff Taylor Marlatt sold 8,516 shares of the firm’s stock in a transaction on Thursday, August 16th. The stock was sold at an average price of $15.50, for a total transaction of $131,998.00. Following the transaction, the senior vice president now directly owns 34,359 shares of the company’s stock, valued at approximately $532,564.50. The disclosure for this sale can be found here. In the last ninety days, insiders sold 31,516 shares of company stock valued at $513,288. Corporate insiders own 1.68% of the company’s stock.
Institutional investors have recently modified their holdings of the stock. M&T Bank Corp acquired a new stake in Owens & Minor during the first quarter valued at $158,000. Itau Unibanco Holding S.A. acquired a new stake in Owens & Minor during the second quarter valued at $170,000. Silvercrest Asset Management Group LLC acquired a new stake in Owens & Minor during the first quarter valued at $164,000. Xact Kapitalforvaltning AB acquired a new stake in Owens & Minor during the first quarter valued at $171,000. Finally, NumerixS Investment Technologies Inc grew its position in Owens & Minor by 74.6% during the second quarter. NumerixS Investment Technologies Inc now owns 11,000 shares of the company’s stock valued at $189,000 after buying an additional 4,700 shares during the period. 89.17% of the stock is owned by hedge funds and other institutional investors.
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare services company in the United States, the United Kingdom, Ireland, France, Germany, and other European countries. It operates through three segments: Domestic, International, and Proprietary Products. The company offers supply chain assistance to the providers of healthcare services; and the manufacturers of healthcare products, supplies, and devices.
See Also: How to Invest in Growth Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.